Top Tech Startups in Dubai, United Arab Emirates in 2027

Steinn Labs had pretty modest beginnings – just a college hustle where we built software for small businesses. As we delved deeper into our work, we realized there was so much untapped potential waiting to be explored. So, we decided to take the leap and expand our team. We hired a bunch of talented individuals, each with their own unique problem-solving skills. This marked a turning point for us, where we went from being a casual college hustle to a serious software development operation. Today, we're not a flashy, high-flying tech giant, but a close-knit team of 25+ engineers and designers. We've taken on a variety of projects, from small local businesses, mid-sized organizations to some pretty big names in the Fortune 500. Our focus has always been on delivering reliable software solutions.‍ We're still as excited as we were on day one, eagerly awaiting the exciting adventures that lie ahead. As a full-service product engineering agency, we work closely with you to define, design and develop great software's that solve complex problems.

Nabta Health (nabtahealth.com) discovers new ways for women to prevent, identify and manage non-communicable diseases (NCDs). The growing epidemic of NCDs threatens the ambition of countries around the world to achieve sustainable, universal access to health and universal health coverage for their populations. NCDs also leave populations more susceptible to communicable diseases such as COVID-19. Moreover, NCDs remain underesearched and underserved in women. Until the mid-1990s, clinical research and clinical trials largely excluded women. Today, women using drugs that were approved pre-1994, are 50–75% more likely than men to suffer adverse reactions to those therapies. Ironically, a significant proportion of the drugs in this category are those designed to treat or manage NCDs. Examples include statins and potassium channel-blockers used to manage cardiovascular disease or hypoglycaemic drugs such as Rezulin used to control diabetes. Standardising and personalising the ways in which women identify and manage NCDs in the context of their own lifestyles and health goals, and through the use of applied machine learning and Artificial Intelligence, will improve clinical outcomes and make cutting-edge healthcare affordable and accessible for all women. Nabta’s unique model of hybrid healthcare seamlessly combines digital health with traditional healthcare to improve health outcomes in women living with NCDs. Nabta’s first hybrid care pathway supports women in preventing, identifying and managing Polycystic Ovary Syndrome (PCOS). PCOS is a hormonal disorder responsible for 70% of female fertility issues. Women who use Nabta’s platform will be able to obtain a formal diagnosis of PCOS within 90 days versus the global average of 2.5 years.